Vaxfab Enterprises Limited has announced the approval of the allotment of 8,26,761 Equity Shares. These shares, with a face value of ₹10 each, were issued at a premium of ₹21.02 per share upon the conversion of warrants. This issuance has led to an increase in the company’s paid-up equity share capital to ₹25,82,64,060.
Board Approves Equity Share Allotment
Vaxfab Enterprises Limited’s Board of Directors, in a meeting held on August 17, 2026, has approved the allotment of 8,26,761 Equity Shares. These shares are valued at a face value of ₹10/- per share and were issued at an aggregate price of ₹21.02/- per share, fully paid up. The allotment took place on a preferential basis following the conversion of warrants into equity shares.
Impact on Paid-Up Capital
The newly allotted equity shares will rank pari-passu in all respects with the existing equity shares of the Company. Following this allotment, the total paid-up equity share capital of Vaxfab Enterprises Limited has increased to ₹25,82,64,060/-. This comprises 2,58,26,406 Equity Shares of a face value of ₹10/- each.
Details of the Allotment
The warrants, which provided the right to subscribe to one equity share per warrant, were initially allotted with a component of the price paid at allotment and the balance at the time of conversion. The total number of investors involved in this conversion is 9. The tenure of the warrants did not exceed 18 months from their date of allotment.
Source: BSE
